Journal
BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES
Volume 56, Issue -, Pages -Publisher
UNIV SAO PAULO, CONJUNTO QUIMICAS
DOI: 10.1590/s2175-97902019000417758
Keywords
Enrofloxacin; HPLC; Piroxicam; Simultaneous determination; Stability-indicating method
Categories
Funding
- CAPES
- FUNDECT/MS [23/200.209/2014]
- CNPq
Ask authors/readers for more resources
We developed and validated a stability-indicating assay method for the simultaneous determination of enrofloxacin and piroxicam in combination and in the presence of degradation products. Reversephase high-performance liquid chromatography analyses were carried out on a Vertisep C18 column and acetonitrile-water (48:52 v/v, pH 3.0) mobile phase with a 1.00 mL min(-1) flow rate. The efficient chromatographic separation of these drugs and their forced degradation products was achieved in less than 5 min with a peak purity match factor higher than 950. The method used showed linearity in the concentration ranges of 0.25 to 16.0 mu g mL(-1) for enrofloxacin (r = 0.9997) and 0.125 to 8.0 mu g mL(-1) for piroxicam (r = 0.9999) as well as precision (relative standard deviation lower than 2%), accuracy (mean recovery 100 +/- 2%), and robustness, according to ICH (International Conference on Harmonization) and AOAC (Association of Official Analytical Chemists) guidelines. This method can simultaneously determine the combination of these drugs in a veterinary formulation and separate the drug peaks from their forced degradation products. Additionally, its optimized chromatographic conditions can contribute to the quality control of this formulation in pharmaceutical manufacturing plants and minimize waste from the organic solvent.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available